AK-POLY-BAC- bacitracin zinc and polymyxin b sulfate ointment
Polymyxin B Sulfate is the sulfate salt of polymyxin B1 and B2 which are produced by the growth of Bacillus polymyxa (Prazmowski) Migula (Fam. Bacillaceae). It has a potency of not less than 6,000 polymyxin B units per mg, calculated on an anhydrous basis. The structural formulae are:
Each gram contains: Bacitracin zinc equal to 500 bacitracin units and polymyxin B sulfate equal to 10,000 polymyxin B units, white petrolatum and mineral oil.
Polymyxin B attacks gram-negative bacilli, including virtually all strains of Pseudomonas aeruginosa and H influenzae species.
Bacitracin is active against most gram-positive bacilli and cocci including hemolytic streptococci.
For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to bacitracin zinc and polymyxin B sulfate
This product is contraindicated in those individuals who have shown hypersensitivity to any of its components.
Ophthalmic ointments may retard corneal healing.
As with other antibiotic preparations, prolonged use may result in overgrowth of nonsusceptible organisms, including fungi. Appropriate measures should be taken if this occurs.
Apply the ointment every 3 or 4 hours for 7 to 10 days, depending on the severity of the infection.
Bacitracin Zinc and Polymyxin B Sulfate ophthalmic ointment USP, sterile, each gram contains bacitracin zinc equal to 500 bacitracin units and polymyxin B sulfate equal to 10,000 polymyxin B units, in a tube of 3.5 g (1/8 oz) with ophthalmic tip.
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Manufactured By: Akorn, Inc.
Lake Forest, IL 60045
Principal Display Panel Text for Container Label:
NDC 17478-238-35 Akorn
brand of Bacitracin Zinc and Polymyxin B Sulfate
Ophthalmic Ointment USP
For Ophthalmic Use Only. Sterile
Rx only Net Wt. 3.5 g (1/8oz.)
| AK-POLY-BAC |
|Labeler — DIRECT RX (079254320)|
|DIRECT RX||079254320||relabel (61919-989)|
Revised: 01/2020 DIRECT RX
RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.